COMMUNICATIONS
Gold-Catalyzed Selective Reductive Transformation
Acknowledgements
Kubo, C. Katoh, K. Okano, H. Tokuyama, T. Fukuya-
ma, Tetrahedron 2008, 64, 11230–11236; c) K. Maruoka,
T. Miyazaki, M. Ando, Y. Matsumura, S. Sakane, K.
Hattori, H. Yamamoto, J. Am. Chem. Soc. 1983, 105,
2831–2843.
Financial support by the National Natural Science Founda-
tion of China (21273044), the Research Fund for the Doctor-
al Program of Higher Education (20120071110011) and Sci-
ence & Technology Commission of Shanghai Municipality
[8] a) A. Sꢄnchez, M. Fang, A. Ahmed, R. A. Sꢄnchez-Del-
gado, Appl. Catal. A 2014, 477, 117–124; b) M. Fang,
R. A. Sꢄnchez-Delgado, J. Catal. 2014, 311, 357–368;
c) Y. Gong, P. Zhang, X. Xu, Y. Li, H. Li, Y. Wang, J.
Catal. 2013, 297, 272–280; d) D. Ren, L. He, L. Yu,
R. S. Ding, Y. M. Liu, Y. Cao, H. Y. He, K. N. Fan, J.
Am. Chem. Soc. 2012, 134, 17592–17598; e) G. E. Do-
bereiner, A. Nova, N. D. Schley, N. Hazari, S. J. Miller,
O. Eisenstein, R. H. Crabtree, J. Am. Chem. Soc. 2011,
(
08DZ2270500 and 12ZR1401500) is kindly acknowledged.
References
[
1] a) A. Mitchinson, A. Nadin, J. Chem. Soc. Perkin
Trans. 1 2000, 2862–2962; b) A. R. Katritzky, S. Rachw-
al, B. Rachwal, Tetrahedron 1996, 52, 15031–15070;
c) V. Sridharan, P. A. Suryavanshi, J. C. Menꢃndez,
Chem. Rev. 2011, 111, 7157–7259.
1
33, 7547–7562; f) N. Hashimoto, Y. Takahashi, T.
Hara, S. Shimazu, T. Mitsudome, T. Mizugaki, K. Jitsu-
kawa, K. Kaneda, Chem. Lett. 2010, 39, 832–834.
[2] a) G. O. Kokwaro, G. Taylor, Drug Chem. Toxicol.
[
9] M. Rueping, R. M. Koenigs, R. Borrmann, J. Zoller,
1
990, 13, 347–354; b) L. J. C. Wong, G. C. Tsao, J. L.
T. E. Weirich, J. Mayer, Chem. Mater. 2011, 23, 2008–
Bruce, S. S. Wong, Experientia 1990, 46, 461–464;
c) N. A. El Ragehy, M. F. El Tarras, F. I. Khattab,
A. K. S. Ahmad, Spectrosc. Lett. 1991, 24, 81–97;
d) K. E. H. El Tahir, A. M. H. Al-Kharji, A. M. Ageel,
Gen. Pharmac. 1992, 23, 131–139; e) R. J. Prankerd,
S. M. Ahmed, J. Pharm. Pharmacol. 1992, 44, 259–261;
f) R. J. Prankerd, S. M. Ahmed, J. Pharm. Pharmacol.
2
010.
10] H. Mao, C. Chen, X. Liao, B. Shi, J. Mol. Catal. A
011, 341, 51–56.
[
[
2
11] a) A. M. Voutchkova, D. Gnanamgari, C. E. Jakobsche,
C. Butler, S. J. Miller, J. Parr, R. H. Crabtree, J. Org.
Chem. 2008, 693, 1815–1821; b) M. Yan, T. Jin, Q.
Chen, H. E. Ho, T. Fujita, L. Y. Chen, M. Bao, M. W.
Chen, N. Asao, Y. Yamamoto, Org. Lett. 2013, 15,
1
992, 44, 261–263.
[
3] a) T. Kimura, S. Imanishi, M. Arita, J. Cardiovasc.
Pharmacol. 1989, 13, 767–773; b) K. Hashimoto, K.
Akiyama, H. Mitsuhashi, Jpn. J. Pharmacol. 1989, 49,
1
484–1487.
[
[
12] K. Meisel, H. Psaar, U. S. Patent 5130442, 1992.
13] a) A. Boddien, F. Gꢅrtner, C. Federsel, P. Sponholz, D.
Mellmann, R. Jackstell, H. Junge, M. Beller, Angew.
Chem. 2011, 123, 6535–6538; Angew. Chem. Int. Ed.
2
45–254; c) J. Weirich, H. Antoni, Naunyn-Schmiede-
berg’s Arch. Pharmacol. 1989, 340, 456–464; d) E.
Rekka, R. M. Mannhold, A. Bast, H. Timmerman, Bio-
chem. Pharmacol. 1990, 39, 95–100; e) J. Weirich, H.
Antoni, J. Cardiovasc. Pharmacol. 1990, 15, 998–1009.
4] a) S. Omura, A. Nakagawa, Tetrahedron Lett. 1981, 22,
2
011, 50, 6411–6414; b) T. Schaub, R. A. Paciello,
Angew. Chem. 2011, 123, 7416–7420; Angew. Chem.
Int. Ed. 2011, 50, 7278–7282; c) D. Preti, C. Resta, S.
Squarcialupi, G. Fachinetti, Angew. Chem. 2011, 123,
[
[
2
199–2202; b) C. L. Francis, A. D. Ward, Aust. J. Chem.
1
2759–12762; Angew. Chem. Int. Ed. 2011, 50, 12551–
1
994, 47, 2109–2117; c) N. M. Williamson, D. R. March,
1
2554.
A. D. Ward, Tetrahedron Lett. 1995, 36, 7721–7724.
5] a) P. D. Leeson, R. W. Carling, K. W. Moore, A. M. Mo-
seley, J. D. Smith, G. Stevenson, T. Chan, R. Baker,
A. C. Foster, S. Grimwood, J. A. Kemp, G. R. Marshall,
K. Hoosteen, J. Med. Chem. 1992, 35, 1954–1968;
b) M. N. Pangalos, P. T. Francis, A. C. Foster, R. C. A.
Pearson, D. N. Middlemiss, D. M. Bowen, Brain Res.
[
14] a) S. Enthaler, ChemSusChem. 2008, 1, 801–804; b) F.
Joꢆ, ChemSusChem. 2008, 1, 805–808; c) H. L. Jiang,
S. K. Singh, J. M. Yan, X. B. Zhang, Q. Xu, ChemSu-
sChem. 2010, 3, 541–549; d) T. C. Johnson, D. J. Morris,
M. Wills, Chem. Soc. Rev. 2010, 39, 81–88; e) A. Ma-
jewski, D. J. Morris, K. Kendall, M. Wills, ChemSu-
sChem. 2010, 3, 431–434.
15] a) A. Fujii, S. Hashiguchi, N. Uematsu, T. Ikariya, R.
Noyori, J. Am. Chem. Soc. 1996, 118, 2521–2522; b) X.
Wu, X. Li, F. King, J. Xiao, Angew. Chem. 2005, 117,
1
992, 596, 223–230; c) A. C. Foster, J. A. Kemp, P. D.
[
Leeson, S. Grimwood, A. E. Donald, G. R. Marshall, T.
Priestley, J. D. Smith, R. W. Carling, Mol. Pharmacol.
1
992, 41, 914–922; d) S. Grimwood, A. M. Moseley,
3
473–3477; Angew. Chem. Int. Ed. 2005, 44, 3407–3411;
R. W. Carling, P. D. Leeson, A. C. Foster, Mol. Pharma-
col. 1992, 41, 923–930; e) Y. Yoneda, T. Suzuki, K.
Ogita, D. Han, J. Neurochem. 1993, 60, 634–644; f) P. P.
Mager, Drug Des. Disc. 1994, 11, 185–196; g) B. Stauch
Slusher, K. C. Rissolo, P. F. Jackson, L. M. Pullan, J.
Neural Transm. Gen. Sect. 1994, 97, 175–185; h) S.
Grimwood, B. Le Bourdelles, P. J. Whiting, J. Neuro-
chem. 1995, 64, 525–530; Chem. Abstr. 1995, 122,
c) O. Soltani, M. A. Ariger, H. Vꢄzquez-Villa, E. M.
Carreira, Org. Lett. 2010, 12, 2893–2895; d) M. Vilches-
Herrera, S. Werkmeister, K. Junge, A. Bçrner, M.
Beller, Catal. Sci. Technol. 2014, 4, 629–632.
[16] A. Kulkarni, R. Gianatassio, B. Tçrçk, Synthesis 2011,
8, 1227–1232.
[17] a) A. S. K. Hashmi, G. J. Hutchings, Angew. Chem.
2006, 118, 8064–8105; Angew. Chem. Int. Ed. 2006, 45,
7896–7936; b) M. Rudolph, A. S. K. Hashmi, Chem.
Soc. Rev. 2012, 41, 2448–2462.
9
6985m.
[6] K. M. Witherup, R. W. Ransom, S. L. Varga, S. M. Pit-
zenberger, V. J. Lotti, W. J. Lumma, U. S. Patent
5
288725, 1994 [Chem. Abstr. 1994, 121, 91779s].
[18] Q. Y. Bi, X. L. Du, Y. M. Liu, Y. Cao, H. Y. He, K. N.
Fan, J. Am. Chem. Soc. 2012, 134, 8926–8933.
[19] See Supporting Information.
[
7] a) R. Omar-Amrani, A. Thomas, E. Brenner, R.
Schneider, Y. Fort, Org. Lett. 2003, 5, 2311–2314; b) T.
Adv. Synth. Catal. 0000, 000, 0 – 0
ꢁ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
7
ÞÞ
These are not the final page numbers!